FBP1 and acute myeloid leukemia: Additionally, our data suggested that FBP1-altered carbohydrate metabolism can affect the normal function of the mitochondria and interfere with metabolic homeostasis in AML blasts, establishing a potential foundation for the utilization of FBP1-based therapeutics to treat AML in vivo.